ARX Gene Early Infantile Epileptic Encephalopathy Type 1 Genetic Test
Welcome to DNA Labs UAE, where we offer the ARX Gene Early Infantile Epileptic Encephalopathy Type 1 Genetic Test. This diagnostic test is specifically designed to detect mutations in the ARX gene, which is responsible for Early Infantile Epileptic Encephalopathy Type 1 (EIEE1), a rare genetic disorder affecting infants and young children.
Test Components and Price
The ARX Gene Early Infantile Epileptic Encephalopathy Type 1 Genetic Test is priced at 4400.0 AED. The test requires a blood sample or extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
The test results will be delivered within 3 to 4 weeks. The test utilizes Next Generation Sequencing (NGS) technology for accurate and rapid sequencing of large amounts of DNA.
Test Type and Doctor
The ARX Gene Early Infantile Epileptic Encephalopathy Type 1 Genetic Test falls under the category of Neurological Disorders. It is recommended to consult with a Neurologist for this test.
Test Department and Pre Test Information
The test is conducted by our Genetics department. It is essential to provide the clinical history of the patient who is undergoing the ARX Gene Early Infantile Epileptic Encephalopathy Type 1 NGS Genetic DNA Test. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected by ARX Gene Early Infantile Epileptic Encephalopathy Type 1.
Test Details
The ARX gene NGS genetic test is a diagnostic test used to detect mutations in the ARX gene. It is specifically designed for the diagnosis of Early Infantile Epileptic Encephalopathy Type 1 (EIEE1), a rare genetic disorder characterized by severe seizures starting in the first few months of life, developmental delay, and intellectual disability.
The ARX gene is responsible for producing a protein vital for brain development. Mutations in this gene can disrupt normal brain development, leading to EIEE1. The ARX gene NGS genetic test involves analyzing the patient’s DNA for mutations in the ARX gene using Next Generation Sequencing (NGS) technology. This test can detect various mutations, including point mutations, insertions, and deletions.
The ARX gene NGS genetic test is typically ordered by a genetic counselor or a healthcare provider who suspects EIEE1 in a patient. A blood sample is required for the test, which is sent to our specialized laboratory for analysis. The test results can confirm a diagnosis of EIEE1, enabling appropriate treatment and management.
Overall, the ARX gene NGS genetic test is a crucial tool for diagnosing EIEE1. Early diagnosis and intervention can significantly improve outcomes for patients with this rare and debilitating condition.
| Test Name | ARX Gene Early infantile epileptic encephalopathy type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ARX Gene Early infantile epileptic encephalopathy type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ARX Gene Early infantile epileptic encephalopathy type 1 |
| Test Details |
The ARX gene NGS genetic test is a diagnostic test that is used to detect mutations in the ARX gene. This test is specifically designed to diagnose Early Infantile Epileptic Encephalopathy Type 1 (EIEE1), a rare genetic disorder that affects infants and young children. EIEE1 is characterized by severe seizures that begin in the first few months of life, developmental delay, and intellectual disability. The ARX gene is responsible for producing a protein that is essential for the development of the brain. Mutations in this gene can disrupt the normal development of the brain, leading to EIEE1. The ARX gene NGS genetic test involves analyzing the DNA of the patient for mutations in the ARX gene. This test uses Next Generation Sequencing (NGS) technology, which allows for the rapid and accurate sequencing of large amounts of DNA. The test can detect a wide range of mutations in the ARX gene, including point mutations, insertions, and deletions. The ARX gene NGS genetic test is typically ordered by a genetic counselor or a healthcare provider who suspects that a patient may have EIEE1. The test requires a blood sample from the patient, which is sent to a specialized laboratory for analysis. The results of the test can help to confirm a diagnosis of EIEE1, which can guide treatment and management of the condition. Overall, the ARX gene NGS genetic test is an important tool for the diagnosis of EIEE1. Early diagnosis and intervention can help to improve outcomes for patients with this rare and debilitating condition. |
